Brief: Lyka Labs Gets Permission From CDSCO To Manufacture, Market Pregabalin Gel 8% W/W In India
14/10/2024 15:24
Oct 14 (Reuters) - Lyka Labs Ltd LYKA.NS :
* GOT PERMISSION FROM CDSCO TO MANUFACTURE, MARKET
PREGABALIN GEL
8% W/W IN INDIA
Source text for Eikon: ID:nBSE90WB6p
Further company coverage: LYKA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lyka Labs
See all newsBrief: Lyka Labs Gets Tribunal Order To Receive 6.3 Million Rupees From Modi Life Care
Brief: Lyka Labs Gets Indian Patent For Pregabalin Gel 8% Valid Through 2043
India's Lyka Labs secures drug patent for diabetes-related conditions; shares surge
India's Lyka Labs climbs after regulatory body approves Pregabalin Gel
Brief: Lyka Labs Gets Permission From CDSCO To Manufacture, Market Pregabalin Gel 8% W/W In India